Cascade Financial Partners, LLC
Position in PLX — Protalix BioTherapeutics, Inc.
CIK 2021208
SAN DIEGO, CA
Position in PLX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$27,960
+$1,920 QoQ
Shares Held
12,000
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 101 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cascade Financial Partners, LLC holds $131,128 across 2 Biotechnology names. PLX ranks #2 (21.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FBLG |
FibroBiologics, Inc.
|
108,828 | $103,168 | |
| 2 | PLX |
Protalix BioTherapeutics, Inc.
This page
|
12,000 | $27,960 |
All Filings in PLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,960 | 12,000 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $26,040 | 12,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $21,600 | 12,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $37,740 | 17,000 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $25,160 | 17,000 | Shares | Sole | 2025-08-07 | |
| 2024-06-30 | $12,987 | 11,100 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||